Effect of a high-protein diet on development of heart failure in response to pressure overload

Applied Physiology, Nutrition and Metabolism

Volumn 39, Issue 2, 2014, Pages 238-247

  Ribeiro Jr , Rogerio F ^a,b   Dabkowski, Erinne R ^a   O'Connell, Kelly A ^a   Xu, Wenhong ^a   Galvao, Tatiana de Fatima ^a,c   Hecker, Peter A ^a   Shekar, Kadambari C ^a   Stefanon, Ivanita ^b   Stanley, William C ^a,d  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Congestive heart failure; Dietary protein; Mitochondria; Mitochondrial permeability transition; Nutrition

Indexed keywords

PROTEIN INTAKE;

ADMINISTRATION AND DOSAGE; ANIMAL; BLOOD PRESSURE; HEART FAILURE; MALE; PROTEIN INTAKE; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD PRESSURE; DIETARY PROTEINS; HEART FAILURE; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84893424746     PISSN: 17155312     EISSN: 17155320     Source Type: Journal    
DOI: 10.1139/apnm-2013-0274     Document Type: Article

References (39)

1. Abel, E. D., and Doenst, T. 2011. Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy. Cardiovasc. Res. 90: 234-242. doi:10.1093/cvr/cvr015. PMID:21257612.
2. Anker, S. D., Negassa, A., Coats, A. J., Afzal, R., Poole-Wilson, P. A., Cohn, J. N., and Yusuf, S. 2003. Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. Lancet, 361: 1077-1083. doi:10.1016/S0140-6736(03)12892-9. PMID:12672310.
3. Aquilani, R., Opasich, C., Gualco, A., Verri, M., Testa, A., Pasini, E., et al. 2008. Adequate energy-protein intake is not enough to improve nutritional and metabolic status in muscle-depleted patients with chronic heart failure. Eur. J. Heart Fail. 10: 1127-1135. doi:10.1016/j.ejheart.2008.09.002. PMID:18835539.
4. Asemu, G., O'Connell, K. A., Cox, J. W., Dabkowski, E. R., Xu, W., Ribeiro, R. F., et al. 2012. Enhanced resistance to permeability transition in interfibrillar cardiac mitochondria in dogs: effects of aging and long term aldosterone infusion. Am. J. Physiol. Heart Circ. Physiol. 304: H514-H528. doi:10.1152/ajpheart.00674.2012. PMID:23241318.
5. Bugger, H., Schwarzer, M., Chen, D., Schrepper, A., Amorim, P. A., Schoepe, M., et al. 2010. Proteomic remodelling of mitochondrial oxidative pathways in pressure overload-induced heart failure. Cardiovasc. Res. 85: 376-384. doi:10.1093/cvr/cvp344. PMID:19843514.
6. Cermak, N. M., Gibala, M. J., and van Loon, L. J. 2012. Nitrate supplementation's improvement of 10-km time-trial performance in trained cyclists. Int. J. Sport Nutr. Exerc. Metab. 22: 64-71. PMID:22248502.
7. Chess, D. J., and Stanley, W. C. 2008. Role of diet and fuel overabundance in the development and progression of heart failure. Cardiovasc. Res. 79: 269-278. doi:10.1093/cvr/cvn074. PMID:18343896.
8. Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J., Ponikowski, P., Poole-Wilson, P. A., et al. 2008. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29: 2388-2442. doi:10.1093/eurheartj/ehn309. PMID:18799522.
9. Doenst, T., Pytel, G., Schrepper, A., Amorim, P., Farber, G., Shingu, Y., et al. 2010. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload. Cardiovasc. Res. 86: 461-470. doi:10.1093/cvr/cvp414. PMID:20035032.
10. Duda, M. K., O'shea, K. M., Tintinu, A., Xu, W., Khairallah, R. J., Barrows, B. R., et al. 2009. Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction. Cardiovasc. Res. 81: 319-327. doi:10.1093/cvr/cvn310. PMID:19015135.
11. Ershow, A. G., and Costello, R. B. 2006. Dietary guidance in heart failure: a perspective on needs for prevention and management. Heart Fail. Rev. 11: 7-12. doi:10.1007/s10741-006-9187-3. PMID:16819572.
12. Evangelista, L. S., Heber, D., Li, Z., Bowerman, S., Hamilton, M. A., and Fonarow, G. C. 2009. Reduced body weight and adiposity with a high-protein diet improves functional status, lipid profiles, glycemic control, and quality of life in patients with heart failure: a feasibility study. J. Cardiovasc. Nurs. 24: 207-215. doi:10.1097/JCN.0b013e31819846b9. PMID:19390338.
13. Galvao, T. F., Brown, B. H., Hecker, P. A., O'Connell, K. A., O'shea, K. M., Sabbah, H. N., et al. 2012. High intake of saturated fat, but not polyunsaturated fat, improves survival in heart failure despite persistent mitochondrial defects. Cardiovasc. Res. 93: 24-32. doi:10.1093/cvr/cvr258. PMID:21960686.
14. Galvao, T. F., Khairallah, R. J., Dabkowski, E. R., Brown, B. H., Hecker, P. A., O'Connell, K. A., et al. 2013. Marine n3 polyunsaturated fatty acids enhance resistance to mitochondrial permeability transition in heart failure, but do not improve survival. Am. J. Physiol. Heart Circ. Physiol. 73: H12-H21. doi:10.1152/ajpheart.00657.2012. PMID:23103493.
15. Garnier, A., Fortin, D., Delomenie, C., Momken, I., Veksler, V., and Ventura-Clapier, R. 2003. Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J. Physiol. 551: 491-501. doi:10.1113/jphysiol.2003.045104. PMID:12824444.
16. He, J., Wofford, M. R., Reynolds, K., Chen, J., Chen, C. S., Myers, L., et al. 2011. Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. Circulation, 124: 589-595. doi:10.1161/CIRCULATIONAHA.110.009159. PMID:21768541.
17. Hecker, P. A., Galvao, T. F., O'Shea, K. M., Brown, B. H., Henderson, R., Jr., Riggle, H., et al. 2012. High-sugar intake does not exacerbate metabolic abnormalities or cardiac dysfunction in genetic cardiomyopathy. Nutrition, 28: 520-526. doi:10.1016/j.nut.2011.09.017. PMID:22304857.
18. Institute of Laboratory Animal Resources. 2011. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23 (revised 2011). National Academy Press, Washington, DC, USA.
19. Kalantar-Zadeh, K., Anker, S. D., Horwich, T. B., and Fonarow, G. C. 2008. Nutritional and anti-inflammatory interventions in chronic heart failure. Am. J. Cardiol. 101: 89E-103E. doi:10.1016/j.amjcard.2008.03.007. PMID:18514634.
20. Khairallah, R. J., Sparagna, G. C., Khanna, N., O'Shea, K. M., Hecker, P. A., Kristian, T., et al. 2010. Dietary supplementation with docosahexaenoic acid, butnoteicosapentaenoicacid, dramaticallyalterscardiacmitochondrialphospholipid fatty acid composition and prevents permeability transition. Biochim. Biophys. Acta, 1797: 1555-1562. doi:10.1016/j.bbabio.2010.05.007. PMID:20471951.
21. Lagiou, P., Sandin, S., Weiderpass, E., Lagiou, A., Mucci, L., Trichopoulos, D., and Adami, H. O. 2007. Low carbohydrate-high protein diet and mortality in a cohort of Swedish women. J. Intern. Med. 261: 366-374. doi:10.1111/j.1365-2796.2007.01774.x. PMID:17391111.
22. Lagiou, P., Sandin, S., Lof, M., Trichopoulos, D., Adami, H. O., and Weiderpass, E. 2012. Low carbohydrate-high protein diet and incidence of cardiovascular diseases in Swedish women: prospective cohort study. BMJ, 344: e4026. doi:10.1136/bmj.e4026. PMID:22735105.
23. Lemon, S. C., Olendzki, B., Magner, R., Li, W., Culver, A. L., Ockene, I., and Goldberg, R. J. 2010. The dietary quality of persons with heart failure in NHANES 1999-2006. J. Gen. Intern. Med. 25: 135-140. doi:10.1007/s11606-009-1139-x. PMID:19882192.
24. Levy, D., Larson, M. G., Vasan, R. S., Kannel, W. B., and Ho, K. K. 1996. The progression from hypertension to congestive heart failure. JAMA, 275: 1557-1562. doi:10.1001/jama.1996.03530440037034. PMID:8622246.
25. Lindenfeld, J., Albert, N. M., Boehmer, J. P., Collins, S. P., Ezekowitz, J. A., Givertz, M. M., et al. 2010. HFSA 2010 Comprehensive Heart Failure Practice Guideline. J. Card. Fail. 16: e1-e194. doi:10.1016/j.cardfail.2010.04.004. PMID:20610207.
26. Mann, D. L., and Bristow, M. R. 2005. Mechanisms and models in heart failure: the biomechanical model and beyond. Circulation, 111: 2837-2849. doi:10.1161/CIRCULATIONAHA.104.500546. PMID:15927992.
27. Neubauer, S. 2007. The failing heart-an engine out of fuel. N. Engl. J. Med. 356: 1140-1151. doi:10.1056/NEJMra063052. PMID:17360992.
28. Nishio, M. L., Ornatsky, O. I., Craig, E. E., and Hood, D. A. 1995. Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats. Can. J. Physiol. Pharmacol. 73 (5): 630-637. doi:10.1139/y95-080. PMID:7585330.
29. 2+-induced permeability transition. J. Mol. Cell. Cardiol. 47: 819-827. doi:10.1016/j.yjmcc.2009.08.014. PMID:19703463.
30. Palmer, J. W., Tandler, B., and Hoppel, C. L. 1977. Biochemical properties of subsarcolemmal and interfibrillar mitochondria isolated from rat cardiac muscle. J. Biol. Chem. 252: 8731-8739. PMID:925018.
31. Palmer, J. W., Tandler, B., and Hoppel, C. L. 1986. Heterogeneous response of subsarcolemmal heart mitochondria to calcium. Am. J. Physiol. 250: H741-H748. PMID:3706549.
32. Papanicolaou, K. N., Ngoh, G. A., Dabkowski, E. R., O'Connell, K. A., Ribeiro, R. F., Stanley, W. C., and Walsh, K. 2012. Cardiomyocyte deletion of mitofusin-1 leads to mitochondrial fragmentation and improves tolerance to ROSinduced mitochondrial dysfunction and cell death. Am. J. Physiol. Heart Circ. Physiol. 302: H167-H179. doi:10.1152/ajpheart.00833.2011. PMID:22037195.
33. Pfeffer, M. A., Pfeffer, J. M., Steinberg, C., and Finn, P. 1985. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation, 72: 406-412. doi:10.1161/01.CIR.72.2.406. PMID:3891136.
34. Preis, S. R., Stampfer, M. J., Spiegelman, D., Willett, W. C., and Rimm, E. B. 2010. Dietary protein and risk of ischemic heart disease in middle-aged men. Am. J. Clin. Nutr. 92: 1265-1272. doi:10.3945/ajcn.2010.29626. PMID:20881068.
35. Rosca, M. G., and Hoppel, C. L. 2010. Mitochondria in heart failure. Cardiovasc. Res. 88: 40-50. doi:10.1093/cvr/cvq240. PMID:20668004.
36. Rosendorff, C., Black, H. R., Cannon, C. P., Gersh, B. J., Gore, J., Izzo, J. L., Jr., et al. 2007. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation, 115: 2761-2788. doi:10.1161/CIRCULATIONAHA.107.183885. PMID:17502569.
37. Rozentryt, P., von Haehling, S., Lainscak, M., Nowak, J. U., Kalantar-Zadeh, K., Polonski, L., and Anker, S. D. 2010. The effects of a high-caloric protein-rich oral nutritional supplement in patients with chronic heart failure and cachexia on quality of life, body composition, and inflammation markers: a randomized, double-blind pilot study. J. Cachexia Sarcopenia Muscle, 1: 35-42. doi:10.1007/s13539-010-0008-0. PMID:21475692.
38. Stanley, W. C., Recchia, F. A., and Lopaschuk, G. D. 2005. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 85: 1093-1129. doi:10.1152/physrev.00006.2004. PMID:15987803.
39. Zaha, V., Grohmann, J., Gobel, H., Geibel, A., Beyersdorf, F., and Doenst, T. 2003. Experimental model for heart failure in rats-induction and diagnosis. Thorac. Cardiovasc. Surg. 51: 211-215. doi:10.1007/s11748-003-0035-2. PMID:14502458.